These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 33664816)

  • 1. T cell immune regulator 1 is a prognostic marker associated with immune infiltration in glioblastoma multiforme.
    Qi C; Lei L; Hu J; Wang G; Liu J; Ou S
    Oncol Lett; 2021 Apr; 21(4):252. PubMed ID: 33664816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GRN is a prognostic biomarker and correlated with immune infiltration in glioma: A study based on TCGA data.
    Xu SM; Xiao HY; Hu ZX; Zhong XF; Zeng YJ; Wu YX; Li D; Song T
    Front Oncol; 2023; 13():1162983. PubMed ID: 37091137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AEBP1 as a potential immune-related prognostic biomarker in glioblastoma: a bioinformatic analyses.
    Liu M; Yu Y; Zhang Z; Chen Z; Chen B; Cheng Y; Wei Y; Li J; Shang H
    Ann Transl Med; 2021 Nov; 9(22):1657. PubMed ID: 34988166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombospondin-1 is a prognostic biomarker and is correlated with tumor immune microenvironment in glioblastoma.
    Qi C; Lei L; Hu J; Wang G; Liu J; Ou S
    Oncol Lett; 2021 Jan; 21(1):22. PubMed ID: 33240428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of the prognosis and immune infiltrates for the BET protein family reveals the significance of BRD4 in glioblastoma multiforme.
    Ye Y; Zhong W; Qian J; Zhang J; Xu T; Han R; Han J; Wang C; Song L; Zeng X; Wang H
    Front Cell Dev Biol; 2023; 11():1042490. PubMed ID: 36711038
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of HOXD10 as a Marker of Poor Prognosis in Glioblastoma Multiforme.
    Li Y; Ma K; Xie Q; Zhang X; Zhang X; Chen K; Kong L; Qian R
    Onco Targets Ther; 2021; 14():5183-5195. PubMed ID: 34737577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of SAA1 as a prognostic biomarker associated with immune infiltration in glioblastoma.
    Cui G; Xiao Y
    Autoimmunity; 2022 Sep; 55(6):418-427. PubMed ID: 35574600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of an immune infiltration/tumor proliferation-related Notch3 nomogram for predicting survival in patients with primary glioblastoma.
    Zheng ZQ; Zhang GG; Yuan GQ; Hao JH; Nie QQ; Zheng MC; Wang Z
    Front Genet; 2023; 14():1148126. PubMed ID: 37284062
    [No Abstract]   [Full Text] [Related]  

  • 9. Integrated profiling identifies caveolae-associated protein 1 as a prognostic biomarker of malignancy in glioblastoma patients.
    Guo Q; Guan GF; Cheng W; Zou CY; Zhu C; Cheng P; Wu AH
    CNS Neurosci Ther; 2019 Mar; 25(3):343-354. PubMed ID: 30311408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Increased TRIM5 is associated with a poor prognosis and immune infiltration in glioma patients].
    Chen Y; Li Q; Zhang J; Gu R; Li K; Zhao G; Yuan H; Feng T; Ou D; Lin P
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2020 Jun; 37(3):469-479. PubMed ID: 32597089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SAA1 Expression as a Potential Prognostic Marker of the Tumor Microenvironment in Glioblastoma.
    Cao K; Jiang X; Wang B; Ni Z; Chen Y
    Front Neurol; 2022; 13():905561. PubMed ID: 35756918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic insights into super-enhancer-driven genes as prognostic signatures in patients with glioblastoma.
    Chen Y; Pan Y; Gao H; Yi Y; Qin S; Ma F; Zhou X; Guan M
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12315-12332. PubMed ID: 37432454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Connective tissue growth factor as an unfavorable prognostic marker promotes the proliferation, migration, and invasion of gliomas.
    Song ZB; Yang HP; Xu AQ; Zhan ZM; Song Y; Li ZY
    Chin Med J (Engl); 2020 Mar; 133(6):670-678. PubMed ID: 32197031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Prognostic Role of Glutathione Peroxidase 1 and Immune Infiltrates in Glioma Investigated Using Public Datasets.
    Lv S; Luo H; Huang K; Zhu X
    Med Sci Monit; 2020 Oct; 26():e926440. PubMed ID: 33085656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of carboxypeptidase Q and its methylation in glioblastoma.
    Liu Q; Wang R; Li Z; Peng Y; Qin W; Peng XM; Liu ZG
    Transl Cancer Res; 2023 May; 12(5):1073-1087. PubMed ID: 37304538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Core Genes and Screening of Potential Targets in Glioblastoma Multiforme by Integrated Bioinformatic Analysis.
    Yang J; Yang Q
    Front Oncol; 2020; 10():615976. PubMed ID: 33718116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of
    Xu X; Zhong Z; Shao Y; Yi Y
    Front Genet; 2021; 12():679097. PubMed ID: 34220951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-omics analyses of CD276 in pan-cancer reveals its clinical prognostic value in glioblastoma and other major cancer types.
    Dai L; Guo X; Xing Z; Tao Y; Liang W; Shi Z; Hu W; Zhou S; Wang X
    BMC Cancer; 2023 Jan; 23(1):102. PubMed ID: 36717836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Gene Co-Expression Network to Identify the Role of CD8 + T Cell Infiltration-Related Biomarkers in High-Grade Glioma.
    Feng P; Li Y; Tian Z; Qian Y; Miao X; Zhang Y
    Int J Gen Med; 2022; 15():1879-1890. PubMed ID: 35228815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.